Dr. Cormac O''Cleirigh Joins Renaissance BioScience Corp. as Chief Business Development Officer
(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/13/16 -- Renaissance BioScience Corp., a leading global yeast technology company, is pleased to announce the appointment of Dr. Cormac O''Cleirigh as the company''s Chief Business Development Officer. A native of Ireland with a Ph.D in Bioprocess Engineering, Dr. O''Cleirigh has extensive experience and expertise at the senior executive level in the global yeast and bakery ingredient industry. He will be based at the Renaissance head office in Vancouver, Canada.
"Cormac is an important addition to our senior management team as we expand the number and range of our business partnerships and collaborations to match the potential we have in developing yeast technologies for the global food, beverage, alcohol, biofuel and pharmaceutical industries," said Dr. John Husnik, Renaissance CEO. He added, "This appointment not only significantly increases our yeast industry expertise but also ensures we incorporate end-use industry and consumer insights into our innovation agenda. We are extremely pleased Cormac has joined us."
"Renaissance brings step-change technological innovation to the global yeast industry, which, through its supply of large volumes of a critical ingredient, underpins multiple other global industries," commented Dr. O''Cleirigh. "With the yeast industry becoming increasingly competitive, technologies developed by Renaissance can provide efficiency improvements, increased functional performance and, ultimately, increased value propositions for our global yeast partners and their customers. This model of in-licensing technology innovation to large-volume manufacturing has been proven to add value in other industries, similar to the way biotech has driven growth in adjacent industries such as functional foods and pharmaceuticals."
Prior to joining Renaissance, Dr. O''Cleirigh was Head of Business Development & Innovation for AB Mauri Global Bakery Ingredients, a division of FTSE 100 listed Associated British Foods plc. In this role, his primary responsibilities included overseeing the division''s strategic business development, with a focus on developing consumer insights, evaluating competitor intelligence and identifying acquisition targets. Other key responsibilities included coordinating the company''s global innovation team and managing the business''s innovation systems and processes.
About Renaissance BioScience Corp.
Renaissance BioScience Corp., a leading global yeast technology company based in Vancouver, Canada, is a privately held applied life sciences company that develops yeast-based platform technologies to solve industrial efficiency and consumer health problems in the food, beverage, alcohol, biofuel and pharmaceutical industries. The wholly owned commercial subsidiaries of Renaissance BioScience Corp. include Renaissance Yeast Inc., which commercializes H2S-preventing wine yeast; Renaissance Ingredients Inc., which commercializes acrylamide-reducing baker''s yeast; and Bright Brewers Yeast Inc., which commercializes beer yeast technologies. Detailed information about the Renaissance group of companies can be accessed at .
Contacts:
For further information or to arrange interviews:
Campbell & Company Strategies Inc.
Steve Campbell
Communications and Public Relations
01 604 888-5267
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.01.2016 - 01:05 Uhr
Sprache: Deutsch
News-ID 1408575
Anzahl Zeichen: 3975
contact information:
Contact person:
Town:
VANCOUVER, BRITISH COLUMBIA
Phone:
Kategorie:
Advertising, PR and Marketing
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 191 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Dr. Cormac O''Cleirigh Joins Renaissance BioScience Corp. as Chief Business Development Officer
"
steht unter der journalistisch-redaktionellen Verantwortung von
Renaissance BioScience Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
